Safety and Immunogenicity of a Canarypox-Vectored HIV Type 1 Vaccine with or without gp120.

Authors :: Belshe, Robert B.
Stevens, Cladd
Gorse, Geoffrey J.
Buchbinder, Susan
Sheppard, Haynes
Stablein, Donald
Self, Steve
McNamara, James
Frey, Sharon
Flores, Jorge
Excler, Jean Louis
Klein, Michel
El Habib, Raphaelle
Duliege, Anne-Marie
Harro, Clayton
Corey, Lawrence
Keefer, Michael
Mulligan, Mark
Wright, Peter
Celum, Connie
Source :: Journal of Infectious Diseases. 5/1/2001, Vol. 183 Issue 9, p1343. 10p. 3 Graphs.
Publication Year :: 2001
Abstract: Presents a study which examined the safety and immunogenicity of a canarypox vector HIV type 1 vaccine with or without gp120 boosting. Methodology; Results; Discussion.

Tools